TABLE 2

Metabolic parameters of raloxifene glucuronidation by liver and intestinal microsomes in human and rat Raloxifene was added to the microsomes with cofactors as described under Materials and Methods. Apparent Km, Vmax, and CLint values were obtained by nonlinear regression of the data points in Fig. 4 and Fig. 6.


Species

Glucuronide

Site

Apparent Km (Ksi)a

Apparent Vmax

Apparent CLint
μM pmol/min/mg μl/min/mg
Human M1 Liverb 14.48 1183 82
Jejunumb 4.89 348 71
Ileumb 8.72 424 49
M2 Liverb 3.63 747 206
Jejunumb 3.68 3711 1008
Ileumb 4.88 3871 793
Rat M1 Liverb 3.04 603 199
Duodnumc 2.42 (26.00)a 750 309
Jejunumc 1.40 (44.31)a 419 300
Ileumc 0.95 (47.80)a 117 124
Colonc 0.85 (74.27)a 145 170
M2 Liverb 4.39 161 37
Duodnumc 13.98 (4.76)a 678 49
Jejunumc 11.93 (6.09)a 368 31
Ileumc 3.518 (23.83)a 39 11


Colonb
0.77
23
30
  • a The constant describing the substrate inhibition interaction (Ksi) was calculated according to eq. 3 as described under Materials and Methods

  • b The parameters were calculated from the data up to 34.7 μM raloxifene using the Michaelis-Menten equation

  • c The parameters were calculated according to eq. 3 as described under Materials and Methods since it showed substrate inhibition (see Results)